Mairs and Power's UTHR Position Overview
Mairs and Power (via Mairs & Power INC) currently holds 350 shares of United Therapeutics Corporation (UTHR) worth $207,543, representing 0.00% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Mairs and Power has initiated a new position in UTHR, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Mairs and Power's United Therapeutics Corporation (UTHR) Holding Value Over Time
Track share changes against reported price movement
Quarterly United Therapeutics Corporation (UTHR) Trades by Mairs and Power
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +350 | New Buy | 350 | $592.98 |
Mairs and Power's United Therapeutics Corporation Investment FAQs
Mairs and Power first purchased United Therapeutics Corporation (UTHR) in Q1 2026, acquiring 350 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mairs and Power has held United Therapeutics Corporation (UTHR) for 1 quarters since Q1 2026.
Mairs and Power's largest addition to United Therapeutics Corporation (UTHR) was in Q1 2026, adding 350 shares worth $207,543.
According to the latest 13F filing for Q1 2026, Mairs and Power's firm, Mairs & Power INC, owns 350 shares of United Therapeutics Corporation (UTHR), valued at approximately $207,543.
As of the Q1 2026 filing, United Therapeutics Corporation (UTHR) represents approximately 0.00% of Mairs and Power's publicly disclosed stock portfolio, making it one of their key holdings.
Mairs and Power's peak holding in United Therapeutics Corporation (UTHR) was 350 shares, as reported at the end of Q1 2026.